GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021)

GeneDx Holdings (WGS) reported Long-Term Deferred Tax of $426000.0 for Q1 2021, up 954.46% quarter-over-quarter from $40400.0 in Q4 2020.

GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has 2 years of Long-Term Deferred Tax data on file, last reported at $426000.0 in Q1 2021.

Long-Term Deferred Tax for Q1 2021 came in at $426000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $426000.0 (changed N/A YoY), and the FY2020 annual result was $40400.0, changed N/A from the prior year.
Long-Term Deferred Tax advanced to $426000.0 in Q1 2021 per WGS's latest filing, from $40400.0 in the prior quarter.
Over five years, Long-Term Deferred Tax peaked at $426000.0 in Q1 2021 and troughed at $12000.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	GeneDx Holdings	1.65 Bn	1.48 Bn	68.21 Mn

Download Data